Akero Therapeutics (AKRO) announced results of analyses supporting the clinical activity of efruxifermin in metabolic dysfunction-associated ...

HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial . Overall, in Cohort A1, 25% of ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024New CM24 biomarkers data presented during the third quarter of ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two predicting serum biomarkers identif ...

Q3 2024 Earnings Call Transcript November 14, 2024 Affimed N.V. beats earnings expectations. Reported EPS is $-1.03, ...

Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the ...

The historic action, which was voted for in a ballot by the National Pharmacy Association (NPA), saw 99% of pharmacy owners ...

Identifying key job-site hazards and advocating for a culture of safety is key to both efficient construction sites and ...

Corewell Health’s Southeast Michigan nurses are now Teamsters. A majority of the 9,618 nurses that work at the former ...

To promote responder safety during Crash Responder Safety Week, consider these key NHTSA initiatives for community engagement ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...